February 10, 2023
Artificial intelligence is changing the way we do things around the world, and the healthcare industry is no exception.
Densitas is a Nova Scotia-based company harnessing AI to develop solutions for digital mammography and the management of patients through breast screening. In particular, they focus on breast density assessments, clinical image quality and breast cancer risk assessment.
“Efficient patient and process management and continuous quality control are essential for population health management, but require scalable solutions,” said founder and CEO Mo Abdolell.
“So, we have focused on the augmented and assistive intelligence that AI provides in support of clinical decision-making and operational efficiencies.”
The efficiency gains from AI are a huge part of what’s making the industry keen on adopting artificial intelligence-based solutions for healthcare, said Mo, adding the nation-wide understaffing crisis coupled with burnout is taking a huge toll on the healthcare industry.
“Administrative tasks are the leading reported causes of burnout for the majority of radiologists. Burnout is real. That’s why we developed the intelliMammo, so that AI automation integrated with digitalization can deliver better reporting and workflow efficiencies as well as better image quality and improved process management,” said Mo.
“What everyone really wants to see is radiologists liberated from tedious and repetitive reporting and administrative burdens that lead to burnout. Such solutions allow them to dedicate more time to interpretive tasks and focus on patient care.”
As Densitas reaches its tenth anniversary, Mo looks back at how the hard work and dedication of their team and partners, coupled with the trust their customers place in them, have been instrumental in helping them get to where they are today.
“Over the past decade, Densitas has seen incredible growth and we are a recognized industry leader in AI for breast health. We have consistently remained ahead of the curve and have been able to adapt and evolve as the market has changed,” he said.
Densitas has established notable deployments in the USA, Canada and Europe, and the company plans to expand to other global markets over the next few years. They have signed agreements for several key partnerships and commercial contracts and have made significant advancements in their software, which continues to solidify their position as a leader in the industry.
AI is becoming an essential part of the healthcare industry. Densitas is leading the way by continuing to push the boundaries of what’s possible.If you’re interested in learning more about their commitment to making a positive impact and improving patient care and access to quality healthcare for all, check out their website.